Related Experiment Video
Updated: Jul 20, 2026
Intralymphatic Immunotherapy and Vaccination in Mice
Published on: February 2, 2014
Feline immunotherapy
Ann M Trimmer1, Craig E Griffin, Wayne S Rosenkrantz
1Animal Dermatology Clinic, San Diego, CA 92111, USA. trimmerderm1@aim.com
Abstract:
Feline allergen specific immunotherapy (ASIT) is considered to be a safe and effective treatment for feline atopy. ASIT is defined as the practice of administering gradually increasing quantities of an allergen extract to an allergic subject. The purpose of which is to reduce or eliminate the symptoms associated with subsequent exposures to the causative allergen. ASIT offers an effective and safe treatment option for cats. Reported success rates range for 60 to 78% in feline atopic patients. Additionally, the reported incidence of side effects in feline atopic patients undergoing ASIT is very low and mainly anecdotal.
